152 related articles for article (PubMed ID: 12711403)
1. Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene.
Herken H; Erdal ME; Böke O; Savaş HA
Eur Psychiatry; 2003 Mar; 18(2):77-81. PubMed ID: 12711403
[TBL] [Abstract][Full Text] [Related]
2. Tardive dyskinesia is not associated with the serotonin gene polymorphism (5-HTTLPR) in Chinese.
Chong SA; Tan EC; Tan CH; Mahendren R; Tay AH; Chua HC
Am J Med Genet; 2000 Dec; 96(6):712-5. PubMed ID: 11121166
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder.
Meira-Lima I; Shavitt RG; Miguita K; Ikenaga E; Miguel EC; Vallada H
Genes Brain Behav; 2004 Apr; 3(2):75-9. PubMed ID: 15005715
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
5. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia.
Semwal P; Prasad S; Bhatia T; Deshpande SN; Wood J; Nimgaonkar VL; Thelma BK
Mol Psychiatry; 2001 Mar; 6(2):220-4. PubMed ID: 11317226
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
[TBL] [Abstract][Full Text] [Related]
7. Negative association between catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia.
Lai IC; Wang YC; Lin CC; Bai YM; Liao DL; Yu SC; Lin CY; Chen JY; Liou YJ
J Neural Transm (Vienna); 2005 Aug; 112(8):1107-13. PubMed ID: 15583953
[TBL] [Abstract][Full Text] [Related]
8. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
[TBL] [Abstract][Full Text] [Related]
9. T102C polymorphisms at the 5-HT2A receptor gene in Turkish schizophrenia patients: a possible association with prognosis.
Herken H; Erdal ME; Erdal N; Aynacioglu S
Neuropsychobiology; 2003; 47(1):27-30. PubMed ID: 12606842
[TBL] [Abstract][Full Text] [Related]
10. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder.
Rotondo A; Mazzanti C; Dell'Osso L; Rucci P; Sullivan P; Bouanani S; Gonnelli C; Goldman D; Cassano GB
Am J Psychiatry; 2002 Jan; 159(1):23-9. PubMed ID: 11772685
[TBL] [Abstract][Full Text] [Related]
11. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity.
Kotler M; Barak P; Cohen H; Averbuch IE; Grinshpoon A; Gritsenko I; Nemanov L; Ebstein RP
Am J Med Genet; 1999 Dec; 88(6):628-33. PubMed ID: 10581481
[TBL] [Abstract][Full Text] [Related]
12. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways.
Frisch A; Postilnick D; Rockah R; Michaelovsky E; Postilnick S; Birman E; Laor N; Rauchverger B; Kreinin A; Poyurovsky M; Schneidman M; Modai I; Weizman R
Mol Psychiatry; 1999 Jul; 4(4):389-92. PubMed ID: 10483058
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia and the serotonin transporter gene.
Rao D; Jönsson EG; Paus S; Ganguli R; Nöthen M; Nimgaonkar VL
Psychiatr Genet; 1998; 8(4):207-12. PubMed ID: 9861638
[TBL] [Abstract][Full Text] [Related]
14. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
[TBL] [Abstract][Full Text] [Related]
15. Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide.
Russ MJ; Lachman HM; Kashdan T; Saito T; Bajmakovic-Kacila S
Psychiatry Res; 2000 Feb; 93(1):73-8. PubMed ID: 10699230
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction.
Coto E; Reguero JR; Alvarez V; Morales B; Batalla A; González P; Martín M; García-Castro M; Iglesias-Cubero G; Cortina A
Clin Sci (Lond); 2003 Mar; 104(3):241-5. PubMed ID: 12605580
[TBL] [Abstract][Full Text] [Related]
17. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT).
Benjamin J; Osher Y; Kotler M; Gritsenko I; Nemanov L; Belmaker RH; Ebstein RP
Mol Psychiatry; 2000 Jan; 5(1):96-100. PubMed ID: 10673775
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor.
Tan EC; Chong SA; Mahendran R; Dong F; Tan CH
Biol Psychiatry; 2001 Jul; 50(2):144-7. PubMed ID: 11526996
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis.
Herken H; Erdal ME
Psychiatr Genet; 2001 Jun; 11(2):105-9. PubMed ID: 11525417
[TBL] [Abstract][Full Text] [Related]
20. Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes.
Han DH; Park DB; Na C; Kee BS; Lee YS
Psychiatry Res; 2004 Nov; 129(1):29-37. PubMed ID: 15572182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
